Home Life Sciences Low Back Pain pipeline Overview, Therapeutics Assessment 2017

Low Back Pain pipeline Overview, Therapeutics Assessment 2017


Low Back PainLow Back Pain pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhance decision-making capabilities and help to create effective counter-strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Sample copy is available at


Companies Involved in Low Back Pain Development are Ache Laboratorios Farmaceuticos SA, Adynxx Inc, AnGes MG Inc, Array BioPharma Inc, Axsome Therapeutics Inc, Boehringer Ingelheim GmbH, Egalet Corp, Frontier Biotechnologies Co Ltd, Gador SA, Grunenthal GmbH, Hisamitsu Pharmaceutical Co Inc, Huons Co Ltd, Immune Pharmaceuticals Inc, KPI Therapeutics Inc, MD Biosciences GmbH etc.

The Low Back Pain pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 6, 9, 2, 1 and 6 respectively.

Report at


Scope of this report:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain. The pipeline guide reviews pipeline therapeutics for Low Back Pain by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Low Back Pain therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Low Back Pain therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Low Back Pain.
  • This research report can: Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Low Back Pain. Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Low Back Pain pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Please enter your comment!
Please enter your name here